Patents Assigned to ST IP Holding AG
  • Formulations of 4-methyl-5-(pyrazin-2-yl)-3H-1,2-dithiole-3-thione, and methods of making and using same
    Patent number: 11426403
    Abstract: This disclosure provides, among other things, compositions comprising quantities of oltipraz crystals, as well as method of making such compositions, and method of treating patients using such compositions.
    Type: Grant
    Filed: March 12, 2019
    Date of Patent: August 30, 2022
    Assignee: ST IP Holding AG
    Inventors: Anthony Chris Garland, Barbara-Jean Anne Bormann-Kennedy, Bomi Framroze, Bret Berner, Michael Edward Grass, Casey Keith Jager, Jay Corey Bloom, Mark Joseph Kastantin
  • Formulations of 4-methyl-5-(pyrazin-2-yl)-3H-l,2-dithiole-3-thione, taste-modified formulations, and methods of making and using same
    Patent number: 11185544
    Abstract: This disclosure provides, among other things, compositions comprising quantities of oltipraz crystals, as well as method of making such compositions, and method of treating patients using such compositions. Taste-modified compositions also are provided.
    Type: Grant
    Filed: March 12, 2019
    Date of Patent: November 30, 2021
    Assignee: ST IP Holding AG
    Inventors: Anthony Chris Garland, Barbara-Jean Anne Bormann-Kennedy, Bomi Framroze, Bret Berner, Michael Edward Grass, Casey Keith Jager, Corey Jay Bloom, Mark Joseph Kastantin, Romain Bachelard
  • Methods of treating viral infections with formulated compositions comprising 4-methyl-5-(pyrazin-2-yl)-3H-1,2-dithiole-3-thione
    Patent number: 11135220
    Abstract: This disclosure provides, among other things, formulated oltipraz compositions comprising stabilized oltipraz crystals, for use in treating a patient who has a viral infection or is at risk of incurring a viral infection. Such viral infections can include a viral infection caused by a coronavirus such as one associated with MERS or SARS, e.g., SARS-CoV-2.
    Type: Grant
    Filed: April 9, 2020
    Date of Patent: October 5, 2021
    Assignee: ST IP Holding AG
    Inventors: Bomi Framroze, Jeffrey A. Gelfand
  • Methods for preparing oltipraz
    Patent number: 10968207
    Abstract: The invention provides improved methods of synthesizing oltipraz, which result in higher overall yield and better purity of the desired product.
    Type: Grant
    Filed: April 21, 2020
    Date of Patent: April 6, 2021
    Assignee: ST IP Holding AG
    Inventor: Bomi P. Framroze
  • METHODS FOR PREPARING OLTIPRAZ
    Publication number: 20200247791
    Abstract: The invention provides improved methods of synthesizing oltipraz, which result in higher overall yield and better purity of the desired product.
    Type: Application
    Filed: April 21, 2020
    Publication date: August 6, 2020
    Applicant: ST IP Holding AG
    Inventor: Bomi P. Framroze
  • Honokiol and magnolol formulations with increased stability and improved uptake, and methods of use thereof
    Patent number: 10328090
    Abstract: Described herein are formulations and methods for treating, managing, or preventing sleeplessness or restlessness, for increasing focus or concentration, or for decreasing anxiety. The formulations comprise honokiol and magnolol, which are present in magnolia bark extract, in admixture with one or more polyunsaturated fatty acids, such as those found in virgin salmon oil. As compared to other lipid formulations of honokiol and magnolol, the formulations show improved stability and increased uptake.
    Type: Grant
    Filed: January 18, 2016
    Date of Patent: June 25, 2019
    Assignee: ST IP Holding AG
    Inventor: Bomi P. Framroze
  • METHODS FOR PREPARING OLTIPRAZ
    Publication number: 20190084971
    Abstract: The invention provides improved methods of synthesizing oltipraz, which result in higher overall yield and better purity of the desired product.
    Type: Application
    Filed: July 20, 2018
    Publication date: March 21, 2019
    Applicant: ST IP Holding AG
    Inventor: BOMI P. FRAMROZE